Company Filing History:
2 out of 4,179 
2 out of 139 
2 out of 822 
Years Active: 2012-2023
Title: The Inventive Journey of John E Harlan in the World of Biomedical Innovations
Introduction: John E Harlan, a prolific inventor based in Lake Zurich, IL, has made significant contributions to the field of biomedical innovations with a total of 4 patents to his name.
Latest Patents:
1. Anti-EGFR antibody-drug conjugates: Harlan's patent on anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates inhibits Bcl-xL. The compositions and methods using such ADCs, as well as the methods for making them, showcase his innovative approach in combating diseases.
2. Antibodies to the receptor of advanced glycation end products (RAGE): His invention of isolated proteins, particularly monoclonal antibodies that bind to RAGE protein, signifies a breakthrough in treating diseases induced by pathophysiological ligands. These antibodies have the ability to inhibit RAGE's binding to its various ligands, offering a novel therapeutic avenue.
Career Highlights: John E Harlan has worked with renowned companies such as Abbott Laboratories Corporation and Abbott Gmbh & Co. Kg, where he has undoubtedly played a pivotal role in driving innovation and research forward.
Collaborations: Throughout his career, Harlan has collaborated with talented individuals like Ulrich Ebert and Jijie Gu, showcasing his ability to work seamlessly with diverse teams to bring groundbreaking ideas to life.
Conclusion: John E Harlan's innovative spirit and commitment to pushing the boundaries of biomedical research are evident in his patents and collaborations. His work not only highlights his expertise but also underscores the importance of collaborative efforts in driving innovation in the field of healthcare and biotechnology.